Trials / Completed
CompletedNCT02465827
Ultrasound-guided Selective Blockade of the Saphenous and Obturator Nerves Following Total Knee Arthroplasty
Selective Blocks for Total Knee Arthroplasty
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Bispebjerg Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aimed to evaluate the efficacy of selective low volume ultrasound-guided blockades of the saphenous and obturator nerves on dynamic and rest pain 24-hours post-operatively for patients undergoing unilateral primary total knee arthroplasty.
Detailed description
A femoral nerve block is the recommended strategy in many surgical centers to supplement multimodal analgesic regime following total knee arthroplasty (TKA) (i.e. both for spinal and general anesthesia). However, a femoral nerve block will often result in quadriceps paralysis, and this will increase the risk for the patient to fall as long as the femoral block have effect. Thus, the search for sensory nerve blocks to stop pain after TKA is a very interesting topic. The saphenous nerve is a purely sensory nerve, and the posterior branch of the obturator nerve is a mixed nerve, where the motor component only affects part of the adductor major muscle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nerve block with ropivacaine | Ultrasound guided nerve blocks of the saphenous and obturator nerve, posterior branch with ropivacaine 0.75% for both nerve branches |
| DRUG | nerve block with ropivacaine and with saline | nerve blocks of the saphenous nerve with ropivacaine 0.75% and obturator nerve, posterior branch with saline |
| DRUG | nerve block with saline | Ultrasound guided nerve blocks of the saphenous and obturator nerve, posterior branch with saline for both nerve branches |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2015-06-09
- Last updated
- 2015-06-09
Source: ClinicalTrials.gov record NCT02465827. Inclusion in this directory is not an endorsement.